Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes

OBJECTIVE: To explore whether treatment with pioglitazone was associated with risk of incident cancer at the 10 most common sites (prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma [NHL], pancreas, kidney/renal pelvis, rectal, and melanoma). RESEARCH DESIGN AND METHODS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ferrara, Assiamira, Lewis, James D., Quesenberry, Charles P., Peng, Tiffany, Strom, Brian L., Van Den Eeden, Stephen K., Ehrlich, Samantha F., Habel, Laurel A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Diabetes Association 2011
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064052/
https://ncbi.nlm.nih.gov/pubmed/21447664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-1067
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi